Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion
Phase 3
Completed
- Conditions
- First Posted Date
- 2006-12-07
- Last Posted Date
- 2012-03-07
- Lead Sponsor
- Axxonis Pharma AG
- Target Recruit Count
- 60
- Registration Number
- NCT00408915
- Locations
- 🇩🇪
Imerem GmbH, Nuremberg, Germany
Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)
Phase 3
Completed
- Conditions
- First Posted Date
- 2006-08-23
- Last Posted Date
- 2012-03-07
- Lead Sponsor
- Axxonis Pharma AG
- Target Recruit Count
- 300
- Registration Number
- NCT00367822
- Locations
- 🇩🇪
IMEREM GmbH, Nuremberg, Germany
© Copyright 2024. All Rights Reserved by MedPath